Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Clinical trial NCT06347198 · UNKNOWN
Trial details
- NCT number
- NCT06347198
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2024-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.